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Introduction: The relationship between arterial cardiovascular disease (CVD) and venous 
thromboembolism (VTE) is debated. The knowledge about lifestyle as a risk factor for CVD 
is substantial, while there are few conclusions are reached on the association between lifestyle 
and VTE. The aim of this review was to assess whether known cardiovascular lifestyle risk 
factors also are associated to the risk of VTE. 
Methods and results: We conducted a PubMed search of the existing literature using key 
words for venous thromboembolism, cardiovascular disease and lifestyle. All of the lifestyle 
factors are established risk factors for CVD. Studies on physical activity and VTE have 
diverging results; being physically active was both associated with decreased and increased 
risk of VTE. In contrast, body mass index (BMI) is recognized as a risk factor for VTE. Only 
two studies are conducted on the relationship between diet and VTE, and they reach opposite 
conclusions. The results on alcohol and VTE were conflicting; this is probably due to 
different study designs and populations. The only study done on coffee and VTE found no 
association. Heavy smoking yields an increased risk of VTE. Psychosocial factors have not 
been investigated in relation to VTE, except self-rported stress, which has been reported to 
increase the risk of pulmonary embolism. Lastly, high socioeconomic status was inversely 
associated with VTE risk. 
Conclusions: BMI is the only clear common risk factor for both CVD and VTE, while more 






Venous thromboembolism (VTE) is the collective term for deep vein thrombosis (DVT) and 
pulmonary embolism (PE). Deep vein thrombosis occurs most commonly as a thrombus in the 
deeper veins of the lower extremity. In some cases, th  thrombus becomes detached from the 
vessel wall, and is transported by the circulation o the pulmonary arteries as an emboli, and is 
known as a pulmonary embolism. Symptoms of DVTs include pain, swelling, redness and 
tenderness, while PE is usually presented by dyspnoe, tachypnoe and pleuritic chest pain. 
DVT and pulmonary embolism have the same pathophysiology and often occur at the same 
time. Of those presenting with an event of DVT, 50-80% have asymptomatic or major PE 
present. Of those presenting with PE, findings of DVT are positive in 80% of the cases (1). 
The incidence of VTE is 1-2 per 1000 in the Western population (2-4), and there are twice as 
many DVTs as pulmonary embolisms (5, 6). Several studies have reported that risk of 
incident VTE increase markedly with age with an incidence from 1 per 100.000 in childhood 
to almost 1% in old age (7). Results from the Tromsø study showed that subjects 70 years or 
older had an 11-fold increased risk of VTE compared to subjects younger than 50 years (8).  
 
VTE is a substantial source to both mortality and morbidity; there are several short- and long-
term complications. The mortality is about 6% and 12% within first month after the diagnosis 
of DVT and PE, respectively (6). Further embolization and death are short-term 
complications, while recurrence, post-thrombotic syndrome and pulmonary hypertension are 
examples of long-term complications. Venous thrombosis ften recur, about 30% develop 
recurrence within a 10-year period (9). Furthermore, 25% of the VTE events develop post-
thrombotic syndrome during a 20 year period (10) with lower leg pain, swelling, stasis 
dermatitis etc. 
 
Already in the 1870, Rudolf Virchow formulated the Virchows triad, which has been the 
foundation in the understanding of the pathophysiology of venous thrombosis. The triad 
includes changes in the blood composition, alterations of blood flow and alterations of the 
vessel wall. To date, the pathophysiology is not fully nderstood, however, there is broad 
agreement that venous thromboembolism is a multifactorial disease involving both genetic, 
acquired and transient factors. These factors can all be seen in terms of the Virchows triad. 
The presence of several factors concurrently is often necessary for thrombosis to develop. 
Genetic components which increase the risk of VTE, are protein C and S deficiency, factor V 
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Leiden mutation, prothrombin 20210A mutation, high concentrations of factor VIII and 
antithrombin deficiency (11). Advancing age, chronic disease, cancer and obesity are 
examples of acquired factors associated with VTE occurrence. 
 
Venous thrombosis is the leading cause of preventable in-hospital deaths in the USA (4). 
Confinements to hospital or nursing homes are risk factors for VTE (12), in a population-
based case-control study, almost 60% of all VTE cases were attributed to institutionalization 
(13) where the hospitalization due to medical illnesses or due to surgery was equal. Surgery 
and trauma are both risk factors for venous thrombosis (11). The risk of surgery can further be 
stratified based on type of surgery, age, and whether cancer is present (14). Neurosurgery and 
hip replacements are examples of procedures with hig  risk of VTE (15). Chronic obstructive 
pulmonary disorder (COPD), congestive heart failure, chronic renal disease, malignancy, 
systemic lupus erythematosus (SLE), neurological disease with extremity paresis, infections 
and central venous catheterization or pacemaker are also associated with increased risk of 
VTE (4, 12, 16). Active cancer accounts for almost 20% of incident VTE events (17). The 
risk of VTE is 7-fold increased among cancer patients, i  fact, VTE is the second leading 
cause of death among cancer-patients (18). In addition, chemotherapy itself increases the risk 
of VTE (19). Conversely, patients with idiopathic VTE have increased risk of cancer for at 
least 2 years after the VTE-diagnosis (20).  
 
Among women, hormonal contraceptives (OC), hormone replacement therapy (HRT), 
pregnancy and puerperium are also risk factors for venous thromboembolism. Women using 
oral contraceptives have 3 to 6 times increased risk compared to non-users. The highest risk 
of VTE occur during the first year of use, but an increased risk of VTE persists until 
discontinuation (21). Use of hormone replacement therapy also yields a 2-3 times higher risk 
of VTE, and the users of HRT have an higher absolute risk of VTE compared to OC users due 
to higher age (22). During pregnancy, normal hematologic changes occur, with increasing 
levels of coagulation factors, fibrinogen and decreasing levels of anticoagulants components 
of the fibrinolytic system (23). This is probably a mechanism which prevents major bleedings 
during birth, however, pregnancy and the post-partum period are transient risk factors for 
venous thromboembolism. Pregnant women have 4 to 5 times higher risk of venous 
thrombosis than non-pregnant women, and the risk seem  to be higher in the third trimester 
compared to the first and the second trimester (24). During the post-partum period, the risk of 




The association between venous thromboembolism and c rdiovascular disease have been 
debated. Traditionally, arterial cardiovascular disease (CVD) and VTE are considered two 
different diseases with different pathophysiology, different treatment and different risk 
factors. However, this has been challenged over the last decade, first by a case-control study 
by Prandoni et al. (26), where they found higher occurrence of carotid plaques in subjects 
with spontaneous DVT, compared to subjects with secondary thrombosis and controls. Since 
then more studies have shown both that VTE is a risk factor for myocardial infarction (MI) 
and stroke (27), and that family history of MI is a risk factor for VTE (8). Also the treatment 
of the two diseases shows similarities; the JUPITER study revealed that rosuvastatin, a statin 
traditionally used to treat high cholesterol to prevent CVD, also yielded a reduction in venous 
thrombotic events (28). In addition, aspirin has shown a possible preventive effect on VTE 
(29), low-molecular weight heparins (LMWH) is known to be effective also in the treatment 
of CVD (30). Lastly, warfarin is a commonly used treatment for both arterial and venous 
thrombosis (31). 
 
In spite of many known risk factors, 25-50% of the VTE cases occur in the absence of any 
recognized risk factors (6). Further investigation of risk factors for VTE can be beneficial for 
risk stratification, prevention of substantial contributions to mortality and morbidity, and 
further understanding of the pathophysiology of venous thromboembolism. Lifestyle is known 
to be associated with risk of arterial cardiovascular disease, in this review we will discuss 
whether known lifestyle cardiovascular risk factors a e related to risk of VTE based on a 
PubMed search of the existing literature using key words for venous thromboembolism, 
cardiovascular disease and lifestyle.  
  
Physical activity and venous thromboembolism 
As mentioned, Virchow’s triad has long been the cornerstone of understanding venous 
thromboembolism; he then postulated that blood stasis, which can be caused by 
immobilization and physical restriction, was one of the main contributors to this disease. 
Contrary, muscle activity yields a distinct decrease in venous pressure, elevation of the blood 
flow, and prevents edema (32-34). Thus, it would be reasonable to believe that physical 
exercise will lower the risk of VTE. However, not much research is done on this particular 




The MEGA-study (35) is a large population-based case-control study, including 3 608 cases 
and 4 252 controls aged 18-70 years (table 1). They investigated whether participating in 
sports activities on a regular basis was associated with the risk of VTE, and found that 
participating in regular sport activities at least once a week yielded a 29% reduced risk of 
VTE, compared to those who did not participate in sport activities. They did not find any 
differences in risk estimates for various frequencis, ntensities or types of sport. Another 
case-control study (36) set out to investigate the relationship of use of oral contraceptives and 
risk of VTE (table 1). They included 196 cases and 746 controls aged 15-44 years. They 
found an increased risk associated with use of OC, but this risk was reduced among those who 
participated in regular and vigorous exercise. A large prospective cohort (37) including 
29 518 Swedish women between 25 and 64 years, studied the relationship between several 
lifestyle factors and risk of VTE (table 1). One of the main findings of their study was that 
women who engaged in strenuous exercise (bicycling, gymnastics/dancing more than once a 
week) were at half the risk of VTE compared to women who led a sedentary lifestyle, whereas 
walking several times a week did not yield the same significant protective effect. The 
Physicians’ Health Study (38) compared risk factors f  CVD, stroke and VTE in 18 662 
healthy male physicians (table 1). Whilst they found exercise to have a protective effect on 
CVD and stroke, it actually yielded an increased risk of VTE, particularly for provoked 
events. A longitudinal study (39), investigating the impact of exercise on elderly people and 
the risk of VTE, reached a similar conclusion (table 1). They included 5 534 participants, 
aged 65 years or older and found that mild-intensity exercise such as walking gave a non-
significant beneficial effect, while strenuous exercise such as jogging was associated with a 
greater risk of VTE compared to no exercise at all. The LITE-study (40), also studied exercise 
as a cardiovascular risk factor and revealed its impact on VTE (table 1). This prospective 
cohort, comprising of 19 293 men and women more than 45 years old found no association 
between physical activity and VTE, but they did reveal a tendency of increased risk with 
increasing levels of activity.  
 
The reason for these very diverging results may lie in the fact that the different studies have 
different study designs (case-controls and cohorts), di similar study populations (only women, 
only men, only elderly etc.) and different methods for classifying physical exercise. It should 
be mentioned that only two case-control studies (35, 36) and one prospective study (37), 
which collected information on physical exercise retrospectively, found a protective effect of 
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exercise on VTE. To collect information retrospectively is a weakness because it could cause 
recall bias. Nevertheless, more studies are needed to be able to understand the relationship 
between physical exercise and VTE.  
 
Body Mass Index and venous thromboembolism 
High body mass index (BMI) is generally related to increased risk of disease, especially 
CVD, heart failure and death (41-43). The mechanism for the relation between high BMI 
and VTE is not fully understood. A French study from 2003 (44) reported a strong 
positive relation between plasminogen activator inhibitor-1 (PAI-1) level and BMI. Being 
the main fibrinolytic inhibitor, it is plausible that increased levels of PAI-1, due to high 
BMI, may yield an increased risk of VTE. Other studies have also suggested that 
increased BMI is associated with higher levels of pr thrombotic factors, such as factor 
VII and fibrinogen (45, 46). In addition, increased l vels of C-reactive protein, tumor 
necrosis factor alpha and interleukin-6 can cause inflammation which in turn may cause 
endothelial damage, promote endothelial adhesion molecule expression and increase 
platelet aggregation (47-50). A recent study showed that increased intraabdominal 
pressure (IAP) is transmitted to the lower extremities, by revealing a positive correlation 
between waist circumference and the femoral vein, and the fact that obese patients had 
higher venous outflow obstruction than lean subjects (51). 
 
Already in 1983, the Framingham study (52) concluded that weight reduction in obese 
women might reduce the risk of pulmonary embolism (table 2). A decade later, the same 
authors again concluded that obesity was a risk factor for PE in The Nurses’ Health Study 
(53) (table 2). Both were prospective cohorts including women. The LITE study (40) 
found BMI to be a strong, independent risk factor for VTE (table 2). In concordance with 
the above mentioned articles about mechanisms, they suggest that this is caused by the 
fact that obesity is associated with venous stasis, nd higher levels of prothrombotic 
factors, but also point out that obese individuals may be more likely to be hospitalized, 
and therefore immobilized. Furthermore, the Physicians’ Health Study (38) found BMI to 
be an even stronger risk factor for VTE than for CVD and stroke (table 2).  
 
In The Tromsø Study (54), a prospective cohort including 6 708 men and women aged 25 
to 84 years, they also found BMI to be a risk factor for VTE, but they concluded that 
waist circumference (WC) is a more accurate measure for obesity and the risk of VTE 
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(table 2). In a review from 2003 (55), they concluded that obesity was only a weak risk 
factor for VTE. As a sharp contrast to previous mentioned articles, Heit et al. (12) 
conducted a nested case-control study, where they concluded that BMI was not a risk 
factor for VTE (table 2). However, they point out tha  their ability to identify an above-
normal BMI was limited because they were missing substantial data on height and weight 
among controls. In a study based on the RIETE registry (56), they enrolled 10 114 
patients in 2007 (table 2). Their aim was to investigate the influence of BMI on mortality 
in patients with VTE and they concluded that obese patients have less than half the 
mortality rate, compared with patients with normal BMI. With this finding, they suggest 
that there exists an “obese paradox” in patients wih VTE. Although they point out that it 
is well known that underweight patients with VTE has a higher risk of major bleeding, 
this still does not explain the lower incidence of fatal PE, or the similar rate of VTE 
recurrence in all BMI groups. They are not able to suggest a pathophysiological 
mechanism responsible for their finding.  
 
It is a clear overweight of those who find BMI to be an independent risk factor, and the 
one article who conclude that BMI is not a risk factor admits to a major weakness, they 
lack information on height and weight on many of the controls. Based on this it is fair to 
conclude that BMI is an established, independent risk factor for VTE.  
 
Diet and venous thromboembolism 
In 1952, Jensen (57) published an article on the decrease in postoperative thromboembolism 
in Norway during the Second World War. He eliminated s veral possible explanations for the 
decrease, and finally concluded that it had to be due to the altered diet during the war years 
(1940-45). Because of war-restrictions the diet in the Norwegian population was low in meat, 
high fat dairies, eggs, fruit, berries, sugar and coffee, and high in vegetables and fish (58). 
Diet and arterial cardiovascular diseases (CVD) has been extensively investigated. Lately, 
several articles have pinpointed that studying dietary patterns has greater value than studying 
isolated nutrients because people usually have complex diets, and nutrients may have 
synergistic effects on one another (59). Dietary patterns and CVD have been shown to be 
strongly related (60, 61). Still, very little is known about venous thromboembolism and 




Not surprisingly, diet has been shown to affect several haemostatic factors like factor VIII, 
fibrinogen, antithrombin III, protein S (62) and platelet count and activity (63), in addition to 
factor VII (62, 63) and PAI-1 (62, 64). These factors are related to VTE in varying degrees 
(65-69). Only two articles are published studying the association between isolated nutrients 
and dietary patterns and risk of venous thromboembolism. The LITE-study, a prospective 
cohort, including almost 15 000 middle-aged adults (70), tested their hypothesis that foods 
rich in B vitamins and ω-3 fatty acids are negatively associated and meat int ke positively 
associated with incident VTE (table 3). They concluded that a diet including more plant foods 
and fish and less red and processed meat is associated with a lower incidence of VTE. They 
also identified dietary patterns by using principal component analysis, and found a non-
significant protective effect among those with the highest prudent dietary scores (high 
consumption of fish, fruit and vegetables) and a significant increased risk associated with high 
western dietary score (high consumption of red, processed meat and saturated fat).  Another 
prospective cohort published two years later, also studied both isolated nutrients and dietary 
patterns, but their conclusion was not in concordance with LITE. The Iowa Women’s Health 
Study (IWHS) (71) including elderly, predominantly white women concluded that a greater 
intake of alcohol was associated with a lower risk of incident VTE, but found no other 
independent associations between diet and VTE (table 3). They also used factor analysis to 
identify dietary patterns. The prudent pattern was characterised by high intake of vegetables, 
fruit, and poultry. Those defined as having a western pattern had a greater intake of processed 
meat, non-cereal whole grains, and added fats and oils. They found no association between 
neither prudent nor western dietary patterns, and risk of VTE.   
 
In the Iowa study (71) it was discussed why their rsults diverged from the results in the LITE 
study (70) first and foremost pointing out the age difference in the two studies. The mean age 
at midpoint in IWHS is 12 years older than the mean age in LITE. They point out that for 
example metabolism change with age, and that nutriet absorption usually declines in addition 
to attenuated kidney function and energy needs. Also, the follow-up in IWHS is 7 years 
longer than in LITE, which may have led to greater di tary misclassification in the older 
IWHS-population. Furthermore, they have used different questionnaires. IWHS have included 
127 questions, while LITE only have 66 questions. This may lead to LITE getting less 
extensive information, but maybe more accurate answers because it is easier to fulfil a shorter 
questionnaire. The fact that the Iowa study only investigates the association in elderly women 
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clearly attenuates their generalizability. Only two studies, with opposite conclusions does not 
give us an answer to the relationship between diet and VTE.  
 
Alcohol and venous thromboembolism 
The association between alcohol consumption and arteri l cardiovascular diseases has been 
extensively investigated, and the conclusion is that moderate alcohol consumption has a 
beneficial effect on CVD (72, 73). Several studies have also indicated that alcohol affects 
numerous factors involved in haemostasis, such as lowering fibrinogen (74-76), factor VII, 
von Willebrand factor and plasma viscosity (76), in addition to inhibiting platelet aggregation 
(77) and yielding an increase in levels of tissue plasminogen activator (74, 75). Still, the 
relationship between alcohol consumption and venous thromboembolism (VTE) is not well 
described, and the results from existing studies ar diverging.  
 
A prospective cohort, including predominantly eldery, white women from Iowa, New Haven 
and East Boston (78), found that light to moderate alcohol consumption was associated with a 
decreased risk of VTE (table 4). However, the finding was only significant in East Boston, 
due to a generally low consumption in Iowa and New Haven. Also a Swedish cohort (37), 
studying lifestyle factors and VTE on a population who consisted of middle-aged women, 
concluded that women who were non-smokers, physically active and had moderate alcohol 
consumption were at lower risk of VTE (table 4). The LITE-study (40), a prospective cohort 
with a median follow up of 8 years, including more than 19 000 middle-aged and elderly men 
and women,  investigated the association between traditional cardiovascular risk factors and 
risk of VTE (table 4). In contrast to the two former mentioned studies, the LITE-study found 
no association between alcohol consumption and risk of VTE. Another prospective cohort 
studying male physicians (38), compared risk factors f  coronary hearth diseases, stroke and 
venous thromboembolism (table 4). They found that alcohol was protective against coronary 
heart disease, but not associated with stroke or VTE. Two case-control studies landed on 
opposite conclusions. One of them, a large study on Dutch men and women (79), found that 
subjects with a history of previous VTE had lower alcohol intake than controls, where 2-4 
glasses per day resulted in the largest beneficial effect (table 4). They also revealed that 
alcohol consumers had a concomitant decrease in fibr ogen; this was suggested as an 
explanation for the decreased risk associated with VTE. In contrast, a French case-control 
study (80) studying several possible risk factors f deep vein thrombosis in medical 
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outpatients found no association between alcohol and VTE (table 4). The only study 
investigating the impact of different alcohol types and risk of VTE is the Iowa Women’s 
Health Study (71) (table 4). This large prospective cohort on elderly women reported an 
observed protective effect of beer consumption only, and no association between wine or 
liquor and risk of VTE.  
 
The diverging results in these studies can to a large extent be explained by different study 
design; most of them are prospective cohorts, but some are case-control studies. Although, the 
largest difference is probably the study populations; some only study elderly, white women, 
others only male physicians, this may have a substantial impact on the results knowing that 
there is generally difference in drinking patterns between elderly and middle aged and 
between men and women. This will attenuate the external generalizability, and make them 
less comparable to each other. How they classify alcohol consumption is also important, the 
Dutch study has more than 10 glasses of alcohol per day as their highest exposure, while the 
Iowa Women’s Health Study only has more than one glass per week as their highest exposure, 
and others use occasional or daily consumption as their only classification (38). The relation 
between alcohol consumption and VTE is still not understood. 
 
Coffee consumption and venous thromboembolism 
Consumption of coffee has been associated with many disorders (81), and there are numerous 
studies concerning coffee consumption and arterial cardiovascular disease. Even the 
University of Tromsø is recognised for the finding of the association between boiled coffee 
and cholesterol-levels (82). However, whether coffee is an independent risk factor for arterial 
cardiovascular disease remains debated. Some studies hav  found an increased risk of 
cardiovascular disease (83-86), some have not found any association (83, 86-88), while others 
have even found an inverse association between coffee intake and CVD incidence (89-92) and 
mortality (91, 93-95). 
 
Only one observational study has investigated the relation between coffee intake and venous 
thromboembolism (71). The Iowa Women’s Health study is a prospective cohort study which 
included almost 40 000 older women, and 1950 events of VTE was registered during a 
follow-up of a median of 13 years (table 5). Their conclusion was that coffee was inversely 
associated to VTE risk in multivariable analyses (adjusted for age, kilojoules, education, 
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smoking status and physical activity), however, the association attenuated after further 
adjustments for diabetes and BMI. 
 
Coffee is a liquid containing many different substances. What first comes to mind is caffeine, 
while other substances are polyphenols, diterpenes, vitamin E and B3, magnesium and 
potassium (81), and it is believed that coffee may h ve both beneficial and detrimental effects 
on health. Caffeine has been associated to stimulation of the central nervous system, acute 
elevation of blood pressure, increased diuresis and metabolic rate (81). Diterpenes (kahweol 
and cafestol) are present in boiled coffee, and have a cholesterol-raising effect, however, this 
effect can be avoided by using paper filter when prepa ing coffee (96). Another compound 
which has been studied is polyphenols. These have antioxidant properties which can affect the 
oxidation of LDL cholesterol, furthermore, they may influence platelet aggregation (97).  
 
Smoking and venous thromboembolism 
Smoking is an established risk factor for cardiovascular disease, however, the findings 
concerning smoking and risk of venous thrombosis are conflicting. Numerous studies have 
not found any association (8, 38, 40, 98, 99), while five prospective studies (37, 53, 100-102) 
and two case-control studies (103, 104) have found a positive association between smoking 
habits and venous thrombosis (table 6). Suggested underlying mechanisms for this association 
have been increased levels of coagulations factors and fibrinogen (105-107), defect 
fibrinolysis (105, 108, 109), impaired endothelial function (110-112) and possibly increased 
platelet aggregation (105, 112). 
 
Among the studies reporting no association between smoking and venous thrombosis are two 
large cohort studies of male physicians (38) and of men and women aged ≥45 years (40). The 
LITE study (40) found no relation between VTE risk and smoking status or number of pack-
years, while the Physicians’ Health Study (38)  repo ted that smoking status is associated to 
CVD, but not to venous thrombosis. Supporting these findings is a meta-analysis published by 
Ageno and co-workers (98) where 21 studies were included, however, only 4 of these were 
prospective cohort studies. Smoking status and risk of venous thrombosis has also been 





Two cohorts including middle-aged women, The Nurses’ H alth Study (53) and the Swedish 
MISS-study (37), found smoking at least 25 cigarettes per day or more than 100.000 
cigarettes ever, compared to never-smokers, was associ ted with increased risk of pulmonary 
embolism or VTE. Supporting results were reported in another Swedish cohort study 
including middle-aged men where smoking >15 cigarettes per day was associated with a 
nearly 3-times increased risk of VTE (101). The Copenhagen City Heart study found an 
association between VTE risk and heavy smoking (≥25 g tobacco per day vs. never smokers) 
(102). A large case-control study (the MEGA-study) also found increased risk of VTE among 
current and former smokers (103). In concordance with the others, daily amounts of cigarettes 
were associated to venous thrombosis in a dose-depen nt manner. Increased risk of VTE was 
also reported in the Danish prospective study “Diet, Cancer and Health” where men and 
women aged 50-64 were included and followed for a median of 10.2 years (100). There was a 
positive association between current smoking and VTE, in addition, smoking >20 cigarettes 
for women, and >30 cigarettes for men, increased th risk of VTE markedly, and the authors 
suggest a possible threshold effect of smoking. Furthermore, the Iowa Women’s Health study, 
including elderly women only, reported a 20% increased risk of VTE among current and 
former smokers, as well as a positive association among the heavy smokers (≥20 pack-years) 
(113) (table 6). However, the association was restricted to provoked VTE only, and cancer-
related VTE was responsible for this association (113). The association between smoking 
duration and risk of VTE has not been assessed (53, 100-102) or was not dose-dependently 
associated (103) with VTE in the abovementioned stuies.  
 
Several explanations for different results have been suggested, where different study designs 
and different populations are two of them. Different classification of smoking habits is 
another explanation. Most of the studies not finding a  association have only studied the 
association between smoking status (current, former and never smoking) and risk of VTE, 
while further investigation of smoking doses has been l ft out. The overall conclusion of 
studies finding an association is that heavy smoking is associated with increased risk of 
venous thrombosis, although the different studies have found different thresholds. A third 
explanation for the conflicting results is confounding since the studies have different 
multivariable models. Only some of them have included important confounders such as 
smoking-attributable disease in the analyses. The Danish study “Diet, cancer and health” 
(100) included analyses for non-cancer related VTE where positive risk estimates remained, 
although not significant. Hansson et al. found similar results in their multivariable analyses 
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where cancer, myocardial infraction, stroke and diabetes mellitus during follow-up were 
included (101). The Iowa Women’s Health Study was the first to report that the observed 
association between smoking and venous thrombosis was driven by cancer (113). 
 
Psychosocial factors and venous thromboembolism 
Hemingway and Marmot defines a psychosocial factor as a measurement that potentially 
relates psychological phenomena to the social environment and to pathophysiological 
changes (114). Some of these factors may be clinical depression and depressive symptoms, 
loneliness and social support, chronic stress, optimism and positive affect. Positive affect 
reflects an individual’s level of pleasurable engagement with the environment, and consists of 
terms like enthusiasm, joy, happiness, excitement and contentment (115). 
 
Psychosocial factors have been related to health, and especially to cardiovascular disease. 
Positive affect and optimism have been related withbeneficial effects on all-cause mortality 
(116) and cardiovascular mortality(117). Conversely, negative traits such as stress (118), 
depression, depressive symptoms, loneliness and lack of social support have been associated 
with higher all-cause mortality (119-121) and cardiovascular mortality (118, 122-124). 
Myocardial infarction has also been associated withstress, both at work and at home, 
financial stress and stressful life events (125). Depression and depressive symptoms have 
been predictive for incident coronary heart disease (CHD) (126, 127). Higher risk of CHD has 
been reported among chronically lonely women (128), and among female homemakers 
reporting loneliness during the day (129). An inverse association between CHD and optimism 
has been reported in cohort studies (130, 131). 
 
There are many proposed mechanisms for the observed associations between psychosocial 
factors and health. Health behavioural factors may be important confounders. Cigarette 
smoking, dietary habits, physical activity, alcohol c nsumption and obesity may depend on 
psychosocial factors as depression or social support. Another explanation may be reverse 
causation. Subjects experiencing more positive traits may have a better health and less pre-
existing disease. The observed associations may also be caused by biological pathways. 
Psychosocial factors have been associated with alterations of the autonomous nerve system, 
the hypothalamic-pituitary-adrenal axis, platelet function, the immune system and 




Knowledge about the association between venous thromboembolism and psychosocial factors 
is limited. Only one observational study aimed to pr s ectively investigate the relation 
between psychosocial factors and venous thromboembolism. Rosengren and co-workers 
found that persistent stress increased the risk of pulmonary embolism among 7 046 middle-
aged men (136) (table 7). Other psychosocial factors, such as depression and depressive 
symptoms, loneliness and social support, optimism and positive affect have not been 
investigated in association with VTE. 
 
Socioeconomic status and venous thromboembolism 
Socioeconomic status (SES) is the expression referring to the social position of an individual 
compared to other members of the same society (137). There are many indicators related to 
SES, however, the three most utilized concepts are education level, occupational status or 
income (138).  
 
To our knowledge, there are four observational studies which have included socioeconomic 
status as one of the variables of interest in their investigation of the association between 
socioeconomic status and venous thromboembolism. Petitti and co-workers did not find any 
association between education (treated as a dichotomous variable, less or more than high 
school level) and VTE in a nested case control with38 cases and 8174 controls conducted in 
1961-1976 among  women aged 18-54 (139) (table 8). Opposite findings was found in another 
cohort study, The Iowa Women’s health study, where about 40.000 women were followed for 
a median of 13 years (113) (table 8). They found that education level of high school or higher 
was associated with decreased risk of VTE in analyses adjusted for age, smoking status, 
physical activity and BMI. Education and household income was investigated in the Danish 
Copenhagen City Heart study (102) (table 8). This is also a prospective cohort study including 
adult men and women. After a median follow-up of 19.5 years, they found an increased risk 
of VTE among participants with low household income compared to middle household 
income, and a decreased risk among those with an education of more than 11 years compared 
to less than 8 years of education in age- and calend r time-adjusted analyses. However, in 
multivariable analyses, only household income was a significant independent risk factor of 
venous thrombosis. A Swedish prospective study including middle-aged men only (136) 
found that occupational class was a risk factor of VTE (table 8). A low occupational class 
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(unskilled or skilled manual workers) was associated with increased risk of VTE compared 
with higher occupational classes. 
 
Socioeconomic status has previously been associated to incident arterial cardiovascular 
disease (140), cardiovascular mortality (141-143) and overall mortality (144, 145) in several 
studies. However, explanations for these findings remain unsolved. One explanation is 
behavioral factors, such as smoking, diet patterns and physical exercise. It is also thought that 
those with higher education have more knowledge about health beneficial behavior (137). 
Another suggestion has been psychological factors; ho e in a lower social class experience 
more job strain, higher work demands and less indivdual control, financial stress, social 
isolation, depressive symptoms etc. than people in higher social classes. A material theory has 
also been discussed. People with high SES have bettr housing, can afford health insurances, 
and have resources to pay for health expenses, etc.. Type of neighborhood (e.g. exposure to 
air pollution, crime etc.) have also been suggested as an explanation. Furthermore, different 
treatment by the health services can also be a reason for the observed effects between SES 
and risk of CVD (115). 
 
Discussion and conclusions  
This paper has reviewed what is known about several ca diovascular lifestyle risk factors; 
physical activity, BMI, diet, alcohol consumption, coffee consumption, smoking, emotional 
states and socioeconomic status and their association to VTE. There are extensive knowledge 
about lifestyle factors and their association to CVD, but the knowledge about lifestyle factors 
and VTE is, as we have shown, scarce. 
 
As we have seen, some of the lifestyle factors might be common risk factors for CVD and 
VTE. High BMI, heavy smoking, stress and low socioeonomic status seem to yield an 
increased risk also in VTE, and a majority of the studies find that moderate alcohol 
consumption is inversely associated to VTE. Other factors like physical activity have shown 
tendencies of opposite effects on the two diseases, con idering that some of the large cohort 
studies find an increased risk of VTE associated with strenuous physical activity. Diet, a solid 
risk factor for CVD, has only been investigated by two studies who reached two opposite 
conclusions in regard to its relationship with VTE. Similarly, coffee and VTE have only been 
studied once. These are factors where it is far too early to predict anything about their 
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association to VTE. Furthermore, several of the existing studies are conducted on specific 
populations including only men or women, and/or narrow age groups. In addition, several 
studies are retrospective and only based on self-report d data. In order to reach a conclusion 
concerning all these lifestyle factors and VTE, more p ospective studies on a general 
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Table 1. Summary of studies on physical activity and venous thromboembolism 
Reference 
(Year) 
Study design Purpose Study 
population 
Main findings 






risk factors and 
risk for VTE 




between arterial risk 
factors and risk of 
VTE 
Glynn et al 
(2005) 
Cohort Compare risk 
factors for the 
competing risk of 
CVD, stroke and 
VTE 
18 662 male 
physicians 40-
84 years old 
Exercise protects 
against CVD and 














The increased risk 
associated with use 
of OR was reduced 
among those who 
exercised 
Van Stralen 










activities reduce the 
risk of VTE 
Van Stralen 
et al (2008) 
Cohort Study weather 
exercise is 
associated with 
risk of VTE in 
elderly 




was associated with 
higher risk of VTE 
Lindqvist et 
al (2008) 
Cohort Explore the 
relationship 
between lifestyle 
factors and VTE 
in women 
29 518 women 
25-64 years old 
Physically active 
women were at 





Table 2. Summary of studies on Body Mass Index (BMI) and venous thromboembolism. 
Reference 
(Year) 
Study design Purpose Study 
population 
Main findings 
Goldhaber et al 
(1983) 
Cohort Assess potential 
risk factors for 
major PE 
3 470 men and 
women, mean 





women is an 
important long-
term risk factor 
for PE 
Goldhaber et al 
(1997) 
Cohort Investigate risk 
factors for PE 
in women 
112 822 women 
30-55 years old 
Obesity is 
associated with 
increased risk of 
PE in women 








BMI is not an 
independent risk 
factor for VTE 




risk factors and 
risk for VTE 
19 293 men and 
women 45-64 
years old 
BMI is a strong 
independent risk 
factor for VTE 
Glynn et al 
(2005) 
Cohort Compare risk 
factors for the 
competing risk 
of CVD, stroke 
and VTE 
18 662 male 
physicians 40-
84 years old 
Higher BMI was 
more strongly 
associated with 
risk of VTE than 
of either CVD or 
stroke 
Barba et al 
(2008) 





10 114 men and 
women 
Obese patients 
with acute VTE 






Borch et al 
(2010) 





subjects at risk 
of VTE 
6 708 men and 
women 25-84 
years old 
BMI is a risk 









Table 3. Summary of studies on diet and venous thromboembolism 
Reference 
(Year) 
Study design Purpose Study 
population 
Main findings 
Steffen et al 
(2007) 
Cohort   Explore the 
relation 
between diet 
and VTE  




A diet including 
more plant food and 
fish and less red and 
processed meat is 
associated with 
lower incidence of 
VTE. 
Lutsey et al 
(2009) 
Cohort Explore the role 





69 years old 
No independent 
association between 












Pahor et al 
(1996) 
Cohort Assess whether 
low to moderate 
alcohol 
consumption 
decreases the risk 
of DVT and PE 
7 959 men and 
women >68 years 
old 
Low to moderate 
alcohol 
consumption is 
associated with a 
decreased risk of 











636/636 men and 
women, mean 
age for cases and 
controls at 











risk factors and 
risk for VTE 





risk factors and 
risk of VTE 
Glynn et al 
(2005) 
Cohort Compare risk 
factors for the 
competing risk of 
CVD, stroke and 
VTE 






CVD, but show no 
relation to VTE 









4 423/5 235 men 
and women, 












Cohort Explore the 
relationship 
between lifestyle 
factors and VTE 
in women 
29 518 women 
25-64 years old 
Moderate alcohol 
consumption is 
related to lower 
incidence of VTE 
in women 
Lutsey et al 
(2009) 
Cohort Explore the role 
of diet in the 
development of 
VTE 
37 393 women 
55-69 years old 
Greater intake of 
alcohol is 
associated with a 
lower risk of 





Table 5. Coffee consumption and venous thromboembolism. 
Reference 
(year) 
Study design Purpose Study 
population 
Main findings 
Lutsey et al 
(2009) 
Cohort Explore the role 
of diet and food 







was associated with 
reduced risk of 
VTE, but the 
association 
diminished when 













Glynn  et al 
(2005) 
Cohort Compare the 
relative risks of 








Current (HR 0.92 
(0.63-1.33) nor former 
(HR 0.92 (0.74-1.16) 
smoking were not risk 
factors for VTE. 











Smoking status and 
pack-years of smoking 
were not associated 
with risk of VTE. 














Smoking status was not 
associated with VTE 
risk (HR 1.15 (0.92-
1.44), neither in case 












risk factors and 
VTE risk 
515 cases and 
1505 controls 
Smoking status is not a 




Cohort Determine the 
impact of 
cardiovascular 
risk factors on 





Smoking status is not a 
risk factor of VTE (HR 
1.04 (0.82-1.33) 
Severinsen 
et al (2009) 









increase risk of VTE 
(♀-HR: 1.52 (1.15-
2.00) ♂-HR: 1.32 
(1.00-1.74). Smoking 
>20 g tobacco/day for 
women and 30g/day 
for men increased the 
risk of VTE markedly. 
Goldhaber 
et al (1997) 










smokers had increased 
risk of PE, 25-34 
cig/day: HR=1.8 (1.2-




Cohort Study long-term 
risk factors for 
VTE 
855 men aged 
50 at baseline. 
Heavy smoking (≥15 g 
tobacco/day) increased 














≥20 years  
≥25g tobacco/day 




Cohort Assess the 
association 
between lifestyle 







ever) increased the risk 
of VTE by 30% 
(HR=1.3 (1.0-1.7)). 








VTE, with the 
joint effect of 
contraceptive 






(1.28-1.60) and former 
(HR=1.23 (1.09-1.38) 
smoking increased the 
risk of venous 
thrombosis, number of 
pack-years was 
associated to the risk of 
VTE, where youngest 
heavy smokers had the 






factors for VTE 
in a active 
population 




Smoking increase the 
risk of VTE (OR: 1.7 
(1.0-2.7) 
Lutsey et al 
(2010) 











Smoking status and 
number of pack-years 
were associated to risk 
of VTE, especially 
provoked VTE. The 
association was 










































association of OC 
use, smoking and 
other factors, and 
unprovoked VTE 
38 cases and 
8174 controls 
Education level and 
risk of VTE are not 
related. 
Rosengren 
et al (2002) 
Cohort Determine 
whether VTE is 







associated to risk of 




Lutsey et al 
(2010) 






factors and VTE 
risk 
40377 women  
≥65 yrs. 
Education at high 
school level 
(HR=0.84 (0.75-
0.94) or higher 
(HR=0.87 (0.77-
0.97) decrease the 
risk of VTE 
compared to 
education less than 
high school. 
Holst et al 
(2010) 








women ≥20 yrs 
Household income 
is inversely related 
to risk of VTE. 
Medium vs. low 
income: HR= 0.82 
(0.70-0.95) 
 
